{"id":"NCT02723084","sponsor":"AbbVie","briefTitle":"A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection","officialTitle":"A Randomized, Open-Label, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection (CERTAIN-2)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-04-08","primaryCompletion":"2017-01-19","completion":"2017-03-24","firstPosted":"2016-03-30","resultsPosted":"2019-02-15","lastUpdate":"2021-07-16"},"enrollment":136,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Hepatitis C Virus","Hepatitis C Virus"],"interventions":[{"type":"DRUG","name":"ABT-493/ABT-530","otherNames":["glecaprevir/pibrentasvir","glecaprevir (ABT-493)","pibrentasvir (ABT-530)"]},{"type":"DRUG","name":"sofosbuvir (SOF)","otherNames":[]},{"type":"DRUG","name":"ribavirin (RBV)","otherNames":[]}],"arms":[{"label":"Arm A","type":"EXPERIMENTAL"},{"label":"Arm B","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this phase 3 study is to evaluate the efficacy and safety of ABT-493/ABT-530 in comparison to sofosbuvir plus ribavirin for 12 weeks in Hepatitis C Virus (HCV) Genotype 2 (GT2) infected participants.","primaryOutcome":{"measure":"Percentage of Participants With Sustained Virologic Response 12 Weeks Post-treatment (SVR12): Non-inferiority of Arm A to Arm B","timeFrame":"12 weeks after the last actual dose of study drug","effectByArm":[{"arm":"Arm A","deltaMin":97.8,"sd":null},{"arm":"Arm B","deltaMin":93.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":6},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["28865152","30868245","29180522"],"seeAlso":["http://www.rxabbvie.com/"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":90},"commonTop":["ANAEMIA","NASOPHARYNGITIS","MALAISE","BLOOD BILIRUBIN INCREASED","HEADACHE"]}}